Last reviewed · How we verify
NCT03464279
Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections
NA trial testing Nudge using Behavioral Economic Interventions in Antibiotics in 2,500 participants. Completed in 30 March 2018.
30 March 2018
Quick facts
| Lead sponsor | University of California, Los Angeles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 2,500 |
| Start date | 29 May 2015 |
| Primary completion | 30 March 2018 |
| Estimated completion | 30 March 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Nudge using Behavioral Economic Interventions
- Standard Practices to Reduce Health System Antibiotic Prescription
Conditions studied
- Antibiotics — all drugs for Antibiotics →
- Upper Respiratory Infections — all drugs for Upper Respiratory Infections →
- Safety-Net Hospitals — all drugs for Safety-Net Hospitals →
- Behavioral Economics — all drugs for Behavioral Economics →
Sponsor
University of California, Los Angeles
Who can join
18 and older, any sex, with Antibiotics or Upper Respiratory Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In an effort to implement Choosing Wisely guidelines and decrease patient harm, we will implement and evaluate a clinician audit-feedback and behavioral "nudge" initiative to reduce low-value antibiotics for URIs. Using a quasi-experiment (pre-post) design, antibiotic prescriptions for URI at LAC+USC Urgent Care Center (intervention site) vs. Olive View-UCLA Urgent Care Center (control site) will used to test the effects of behavioral "nudge" on antibiotic prescribing.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Choosing Wisely interventions to reduce antibiotic overuse in the safety net.
Leuchter RK, Sarkisian CA, Trotzky-Sirr R, Wei EK, et al · · 2023 · cited 2× · PMID 37870542 · DOI 10.37765/ajmc.2023.89367
Verify or expand the search:
- PubMed search for NCT03464279
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Antibiotics
Currently open trials in the same condition.
- NCT07016217 — Evaluation of an Educational Intervention on Antibiotics in Dental Care · NA · active not recruiting
- NCT06708689 — Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments · active not recruiting
- NCT04669717 — Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies · Phase 4 · recruiting
- NCT05052619 — Preventive Therapy of Postoperative Intra-abdominal Infection Based on Serum Lactate Changes · NA · recruiting
- NCT03927079 — Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage · NA · active not recruiting
Other University of California, Los Angeles trials
Trials by the same sponsor.
- NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
- NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
- NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03464279 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
- Last refreshed: 2 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03464279.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing